Abbott LaboratoriesAbbott LaboratoriesAbbott Laboratories

Abbott Laboratories

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪178.70 B‬USD
‪5.70 B‬USD
‪40.11 B‬USD
‪1.73 B‬
Beta (1Y)

About Abbott Laboratories

Robert B. Ford
Abbott Park
Employees (FY)
‪114 K‬
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Revenue to profit conversion
Debt level and coverage

See all ideas 

Summarizing what the indicators are suggesting.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ABT is 104.02 USD — it has decreased by 0.63% in the past 24 hours. Watch Abbott Laboratories stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Abbott Laboratories stocks are traded under the ticker ABT.
ABT stock has risen by 0.62% compared to the previous week, the month change is a 0.74% rise, over the last year Abbott Laboratories has showed a 2.85% decrease.
We've gathered analysts' opinions on Abbott Laboratories future price: according to them, ABT price has a max estimate of 143.00 USD and a min estimate of 107.00 USD. Watch ABT chart and read a more detailed Abbott Laboratories stock forecast: see what analysts think of Abbott Laboratories and suggest that you do with its stocks.
ABT reached its all-time high on Dec 27, 2021 with the price of 142.60 USD, and its all-time low was 0.11 USD and was reached on Oct 4, 1974. View more price dynamics on ABT chart.
See other stocks reaching their highest and lowest prices.
ABT stock is 4.94% volatile and has beta coefficient of 0.53. Track Abbott Laboratories stock price on the chart and check out the list of the most volatile stocks — is Abbott Laboratories there?
Today Abbott Laboratories has the market capitalization of ‪182.10 B‬, it has decreased by 0.93% over the last week.
Yes, you can track Abbott Laboratories financials in yearly and quarterly reports right on TradingView.
Abbott Laboratories is going to release the next earnings report on Oct 16, 2024. Keep track of upcoming events with our Earnings Calendar.
ABT earnings for the last quarter are 1.14 USD per share, whereas the estimation was 1.11 USD resulting in a 3.16% surprise. The estimated earnings for the next quarter are 1.21 USD per share. See more details about Abbott Laboratories earnings.
Abbott Laboratories revenue for the last quarter amounts to ‪10.38 B‬ USD, despite the estimated figure of ‪10.37 B‬ USD. In the next quarter, revenue is expected to reach ‪10.57 B‬ USD.
ABT net income for the last quarter is ‪1.22 B‬ USD, while the quarter before that showed ‪1.59 B‬ USD of net income which accounts for −23.17% change. Track more Abbott Laboratories financial stats to get the full picture.
Yes, ABT dividends are paid quarterly. The last dividend per share was 0.55 USD. As of today, Dividend Yield (TTM)% is 2.03%. Tracking Abbott Laboratories dividends might help you take more informed decisions.
Abbott Laboratories dividend yield was 1.89% in 2023, and payout ratio reached 63.81%. The year before the numbers were 1.75% and 49.05% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jul 18, 2024, the company has ‪114.00 K‬ employees. See our rating of the largest employees — is Abbott Laboratories on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Abbott Laboratories EBITDA is ‪9.68 B‬ USD, and current EBITDA margin is 24.13%. See more stats in Abbott Laboratories financial statements.
Like other stocks, ABT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Abbott Laboratories stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Abbott Laboratories technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Abbott Laboratories stock shows the neutral signal. See more of Abbott Laboratories technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.